Charles River Laboratories said demand for its services is building back up after nearly a year of uncertainty around tariffs and drug pricing. With “tariff stuff being sort of over, and whatever pricing situations between Washington and pharma companies, we think that’s sort of passed them. So demand seems to be improving,” Charles River CEO Jim Foster said Wednesday during the company’s 2025 earnings results. Charles River said it still in plans to divest parts of its business. It’s in discussions with potential buyers and expects to close those transactions in the middle of 2026, Foster said.
Read the full article: Charles River Sees Demand Increase, Says Clients Are ‘Back to Work’ as Tariff Uncertainties Fade //
Source: https://endpoints.news/charles-river-highlights-increase-in-demand-as-tariff-uncertainties-fade/